Emphasis on Product (Instruments, Consumables and Reagents); Technology (Immunohistochemistry, In-situ Hybridization, Digital Pathology and Workflow Management, Others); Application (Prostate Cancer, Breast Cancer, Lung Cancer, Gastric Cancer, Other Cancers); End-User (Diagnostic Laboratories, Hospitals, Contract Research Organizations (CROs), Others); Country
MENA Tissue Diagnostic Market Size & ForecastThe MENA Tissue Diagnostic market was valued at USD 253.18 million in 2023 and is expected to grow at a CAGR of 7.36% during the forecast period (2024-2032) due to the rising prevalence of cancer, Investments in healthcare infrastructure, and the establishment of advanced diagnostic facilities.
Tissue diagnostics involves the examination of tissue samples collected from patients for the detection of diseases such as cancer and infectious diseases. The MENA region is experiencing a rise in the incidence of cancer, driven by factors such as population growth, aging, and lifestyle changes. In 2022, the National Institute of Health stated that there were 463,675 new cancer cases estimated to be in Arab countries, corresponding to 2.4% of the global incidence. The ASIR for Arab females was 137.7/100,000, compared with the 186/100,000 population rate of WFCs. Many countries in the MENA region are investing in their healthcare infrastructure, including diagnostic facilities. With advancements in molecular diagnostics, there is a growing trend toward personalized medicine, which involves tailoring treatment plans based on the individual characteristics of patients. This shift is likely to drive demand for molecular tissue diagnostic tests in the MENA region.
Moreover, the governments and private sectors are investing in upgrading healthcare infrastructure, including diagnostic facilities equipped with advanced tissue diagnostic technologies. Moreover, efforts are underway to enhance the skills of healthcare professionals through training programs and partnerships with international institutions to ensure proficient operation of tissue diagnostic technologies.
This section discusses the key market trends that are influencing the various segments of the MENA tissue diagnostic market as identified by our team of research experts.
Consumables and Reagents Transforming Industry
As the volume of tissue diagnostic tests continues to rise, so does the demand for consumables and reagents. Additionally, with the increasing adoption of molecular diagnostics in tissue diagnostics, there is a growing demand for specialized reagents tailored to molecular testing applications. The market for consumables and reagents in tissue diagnostics is further propelled by factors such as the growing prevalence of chronic diseases, advancements in diagnostic techniques, and expanding healthcare infrastructure. For instance, in February 2022, according to an article published by the American Society of Clinical Oncology Journal, more than 436 million people in the Middle East and North Africa region have cancer, with men making up 51.8% of those cases and women making up the remaining 48.2% in Saudi Arabia. New cancer cases were 463,675 in total, corresponding to 2.4% of the global incident cases, and male’ cancers accounted for 47.3% of that number, compared with 52.7% globally.
UAE is Expected to Grow with Significant CAGR During Forecast Period
The UAE is expected to grow with a significant CAGR during the forecast period (2024-2032). With a rapidly growing population and a strong emphasis on healthcare infrastructure development,the UAE has become a hub for medical innovation and advanced diagnostics. The country’s commitment to healthcare excellence is evident through initiatives like the Dubai Health Strategy 2021, which prioritizes adopting innovative technologies to enhance patient care. Early disease detection and personalized treatment planning align with the UAE’s vision for preventive healthcare and precision medicine. For instance, in February 2021, the Advanced Medical Technology Association (AdvaMed) inked an MoU, entering a formal relationship with MECOMED, MEA’s medical devices, imaging, and diagnostics trade association. The collaboration facilitated information sharing between both organizations and increased the ability to strengthen this market. Moreover, the UAE’s strategic location and thriving medical tourism sector further contribute to the demand for tissue diagnostic services, attracting patients from across the region seeking world-class healthcare facilities and expertise.
The MENA Tissue Diagnostic market is competitive and fragmented, with the presence of several MENA and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are Roche Diagnostics Middle East, Abbott, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., The Menarini Group, Sakura Finetek USA, Inc., AFMS (Abdulla Fouad For Medical Supplies & Services).
The MENA Tissue Diagnostic market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirement.
1. Market Introduction
2. Research Methodology Or Assumption
3. Executive Summary
4. Market Dynamics
5. Pricing Analysis
6. Mena Tissue Diagnostic Market Revenue (usd Mn), 2022-2032f
7. Market Insights By Product
8. Market Insights By Technology
9. Market Insights By Application
10. Market Insights By End-user
11. Market Insights By Countries
12. Value Chain Analysis
13. Competitive Landscape
14. Company Profiled
15. Acronyms & Assumption
16. Annexure
Analyzing the historical market, estimating the current market, and forecasting the future market of the MENA Tissue Diagnostic market were the three major steps undertaken to create and analyze the adoption of MENA Tissue Diagnostic in major regions of MENA. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the MENA Tissue Diagnostic market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Step 1: In-Depth Study of Secondary Sources:
A detailed secondary study was conducted to obtain the historical market size of the MENA Tissue Diagnostic market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the MENA Tissue Diagnostic market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product, technology, application, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the MENA Tissue Diagnostic market. Further, we conducted factor analysis using dependent and independent variables such as product, technology, application, and end-user of the MENA Tissue Diagnostic market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the MENA Tissue Diagnostic market sector across the globe.
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the MENA Tissue Diagnostic market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to varied factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets of MENA. The research methodology adopted to estimate the market size encompasses:
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the MENA Tissue Diagnostic market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the product, technology, application, and end-user in the MENA Tissue Diagnostic market.
The current & future market trends of the MENA Tissue Diagnostic market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the current market size and growth potential of the MENA Tissue Diagnostic market?
Q2: What are the driving factors for the growth of the MENA Tissue Diagnostic market?
Q3: Which segment has the largest MENA Tissue Diagnostic market share by technology?
Q4: What are the trends in the MENA Tissue Diagnostic market?
Q5: Which region will dominate the MENA Tissue Diagnostic market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
